Triazolevernetzte macrocyclische Peptide
European patent · EP2114428 · Deleted
Register entry
- Publication number
- EP2114428
- Application number
- EP08730678
- Kind
- European patent with effect for Switzerland and Liechtenstein
- Status
- Deleted
- Specification
- Granted
- Filed
- Feb 25, 2008
- Published
- Nov 11, 2009
- Granted
- Oct 31, 2012
- Deleted
- Feb 29, 2020
- Reason
- Annual fee unpaid
- IPC classes
- A61K 38/00 (2006.01)
- Priority
- US 903073 P 23.02.2007
- PCT application
- PCT/US2008/054922 25.02.2008
- PCT publication
- WO2008/104000 28.08.2008
- Filing language
- English
- Source
- Swissreg
History
What the Federal Institute of Intellectual Property published about this title, newest first.
- Sep 23, 2020
Deleted, fee unpaid
Published in Swissreg on 23.09.2020
- Jan 16, 2013
Agent entered
- Representative
- E. Blum & Co. AG, Patent- und Markenanwälte VSP, Vorderberg 11, 8044 Zürich
Published in Swissreg on 16.01.2013
- Dec 28, 2012
Address changed
- Owner
- Aileron Therapeutics, Inc., 840 Memorial Drive, Cambridge, MA 02139, USA → Aileron Therapeutics, Inc., 281 Albany Street, Cambridge, MA 02139, USA
Published in Swissreg on 28.12.2012
- Oct 31, 2012
Granted
Published in Swissreg on 31.10.2012
Parties
Inventor
NASH, Huw, M.
Concord, MA 01742, US
The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.